INTERNATIONAL PATENT: VANDERBILT UNIVERSITY FILES APPLICATION FOR "GENERATION OF HUMAN ALPHA-GAL- AND TICK-SPECIFIC IGE MONOCLONAL ANTIBODIES FOR DIAGNOSTIC AND THERAPEUTIC USE"

GENEVA, Jan. 6 -- VANDERBILT UNIVERSITY (305 Kirkland Hall2201 West End AvenueNashville, Tennessee 37240) filed a patent application (PCT/US2025/035156) for "GENERATION OF HUMAN ALPHA-GAL- AND TICK-SPECIFIC IGE MONOCLONAL ANTIBODIES FOR DIAGNOSTIC AND THERAPEUTIC USE" on Jun 25, 2025. With publication no. WO/2026/006386, the details related to the patent application was published on Jan 02, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SMITH, Scott A. (c/o Vanderbilt University Medical CenterA2210 Medical Center North1161 21st Avenue SouthNashville, Tennessee 37232)

Abstract: The present ...